Novakand Pharma AB (FRA:3EE0) Net Margin %: 0.00% (As of Dec. 2025)


What is Novakand Pharma AB Net Margin %?

Novakand Pharma AB FRA:3EE0 Net Margin % is 0.00% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 946 Biotechnology companies, Novakand Pharma AB ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Novakand Pharma AB's Net Income for the three months ended in Dec. 2025 was €-0.46 Mil. Novakand Pharma AB's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, Novakand Pharma AB's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Novakand Pharma AB's Net Margin % or its related term are showing as below:


FRA:3EE0's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Novakand Pharma AB  (FRA:3EE0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Novakand Pharma AB Net Margin % Related Terms

Novakand Pharma AB Net Margin % Historical Data

* Premium members only.

The historical data trend for Novakand Pharma AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novakand Pharma AB Net Margin % Chart

Novakand Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,679.52 -7,020.59 0.00 0.00 0.00

Novakand Pharma AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:3EE0 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Novakand Pharma AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novakand Pharma AB Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novakand Pharma AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Novakand Pharma AB's Net Margin % falls into.


Novakand Pharma AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Novakand Pharma AB's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.34/0
= %

Novakand Pharma AB's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.457/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Novakand Pharma AB (FRA:3EE0) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Novakand Pharma AB and its competitors. According to the industry distribution chart, Novakand Pharma AB ranks #999999 out of 946 companies in the Biotechnology industry.
Is Novakand Pharma AB's Net Margin % too high?
Novakand Pharma AB's current Net Margin % is 0.00%. Based on the distribution chart, Novakand Pharma AB ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Novakand Pharma AB's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Novakand Pharma AB ranks #999999 out of 946 companies for Net Margin %. This places Novakand Pharma AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Novakand Pharma AB and its competitors. Novakand Pharma AB's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novakand Pharma AB stock overvalued right now?
Novakand Pharma AB (FRA:3EE0) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Novakand Pharma AB (FRA:3EE0), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novakand Pharma AB Business Description

Address Nanna Svarts vag 4, Solna, SWE, 171 65
Novakand Pharma AB is developing a new class of innovative drugs focusing on inflammatory diseases and cancer. The company is developing a new class of small molecule drugs that control disease promoting immune cells with precision, by targeting the fractalkine axis.